Loading
JPXHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
¥3,766
−¥23.00 · -0.61%
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
Latest quote
¥3,766
−¥23.00 · -0.61%
Regular session · JST · Market data may be delayed.
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
Day range
Current ¥3,766
52-week range
Current ¥3,766
Regular session · JST · Market data may be delayed.
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
Day range
Current ¥3,766
52-week range
Current ¥3,766
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 192.62B JPY | 181.09B JPY | 150.85B JPY | 140.04B JPY | 129.55B JPY |
| Cost of goods sold | 101.1B JPY | 90.51B JPY | 82.03B JPY | 71.76B JPY | 63.08B JPY |
| Gross profit | 91.52B JPY | 90.58B JPY | 68.82B JPY | 68.28B JPY | 66.47B JPY |
| Research and development | — | 8.36B JPY | 8.29B JPY | 7.59B JPY | 7.31B JPY |
| Selling, general, and administrative | 56.3B JPY | 42.1B JPY | 40.51B JPY | 39.77B JPY | 36.78B JPY |
| Operating expenses | 56.3B JPY | 50.46B JPY | 48.8B JPY | 47.37B JPY | 44.09B JPY |
| Interest income | 573M JPY | 628M JPY | 671M JPY | 531M JPY | 443M JPY |
| Interest expense | 1.05B JPY | 518M JPY | 330M JPY | 398M JPY | 173M JPY |
| Depreciation and amortization | 13.06B JPY | 11.17B JPY | 10.75B JPY | 10.61B JPY | 9.19B JPY |
| Operating income | 35.22B JPY | 40.13B JPY | 20.02B JPY | 20.92B JPY | 22.38B JPY |
| Net income | 28.12B JPY | 32.43B JPY | 16.71B JPY | 16.48B JPY | 18.84B JPY |
Company facts updated Sep 15, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥136
2025 complete year+112.5% since 2021
2026 partial: ¥79.00
¥64.00
2,021
¥64.00
2,022
¥67.00
2,023
¥118
2,024
¥136
2,025
¥79.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥79.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥79.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥79.00Semi-Annual | Mar 31, 2026 | Jun 29, 2026 |
Dividend | Sep 29, 2025 | ¥68.00Semi-Annual | Sep 30, 2025 | Dec 5, 2025 |
Dividend | Mar 28, 2025 | ¥68.00Semi-Annual | Mar 31, 2025 | Jun 30, 2025 |
Dividend | Sep 27, 2024 | ¥68.00Semi-Annual | Sep 30, 2024 | Dec 5, 2024 |
Ex-dividend Sep 29, 2026
¥79.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥79.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥79.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 29, 2026
Ex-dividend Sep 29, 2025
¥68.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 5, 2025
Ex-dividend Mar 28, 2025
¥68.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 30, 2025
Ex-dividend Sep 27, 2024
¥68.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 5, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T662.74M0.02%2.9T JPY0.05%¥415.1-0.43%
Vanguard Total International Stock ETFVXUS22.86M0.00%646.2B USD0.05%$85.69-0.41%
Vanguard FTSE Developed Markets ETFVEA15.41M0.00%315B USD0.03%$71.53-0.26%
iShares Core MSCI EAFE ETFIEFA11.13M0.01%194.75B USD0.07%$98.30-0.39%
Dimensional - International Small Cap Value ETFDISV6.5M0.13%5.19B USD0.42%$44.05-0.09%
iShares MSCI EAFE Small-Cap ETFSCZ5.03M0.04%12.96B USD0.40%$85.08-0.53%
Dimensional - International Small Cap ETFDFIS3.73M0.06%5.79B USD0.39%$36.73-0.03%
Vanguard FTSE All-World ex-US ETFVEU3.58M0.00%95.9B USD0.04%$83.78-0.37%iShares Core TOPIX ETF1475.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFADimensional - International Small Cap Value ETFDISViShares MSCI EAFE Small-Cap ETFSCZDimensional - International Small Cap ETFDFISVanguard FTSE All-World ex-US ETFVEUAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
